Author

Xiaonan Cui

Institution: First Affiliated Hospital of Dalian Medical University

Observed institution: First Affiliated Hospital of Dalian Medical University

ORCID: 0009-0006-1269-3053

Observed ORCID: 0009-0006-1269-3053

OpenAlex ID: A5061083684

The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy

2023 · Chenglin Lu, Ying Liu, et al. · Frontiers in Immunology · 164

Advances in metabolic reprogramming of NK cells in the tumor microenvironment on the impact of NK therapy

2024 · Linxuan Miao, Chenglin Lu, et al. · Journal of Translational Medicine · 95

The emerging role of brain neuroinflammatory responses in Alzheimer’s disease

2024 · Mandana Amelimojarad, Melika Amelimojarad, et al. · Frontiers in Aging Neuroscience · 36

Pan-cancer analysis of CTNNB1 with potential as a therapeutic target for human tumorigenesis

2023 · Mandana AmeliMojarad, Melika AmeliMojarad, et al. · Informatics in Medicine Unlocked · 22

Research progress on the role of tumor‑associated macrophages in tumor development and their use as molecular targets (Review)

2023 · Chenglin Lu, Ying Liu, et al. · International Journal of Oncology · 19

Prospective role of PD-1/PD-L1 immune checkpoint inhibitors in GI cancer

2023 · Mandana AmeliMojarad, Melika AmeliMojarad, et al. · Pathology - Research and Practice · 14

Weighted gene co-expression network analysis identified GBP2 connected to PPARα activity and liver cancer

2024 · Mandana AmeliMojarad, Melika AmeliMojarad, et al. · Scientific Reports · 7

Discovering the lipid metabolism-related hub genes of HCC-treated samples with PPARα agonist through weighted correlation network analysis

2024 · Melika AmeliMojarad, Mandana AmeliMojarad, et al. · Scientific Reports · 6

An overview on the impact of viral pathogens on Alzheimer's disease

2024 · Melika AmeliMojarad, Mandana AmeliMojarad, et al. · Ageing Research Reviews · 4

Liposomal irinotecan combined with 5-FU/LV and bevacizumab as second-line therapy for metastatic colorectal cancer: A multicenter, single-arm phase II study (IRIS).

2026 · Xuhua Hu, Bo Jiang, et al. · Journal of Clinical Oncology

Works count: 10

Citation count: 367

H-index: 7

I10-index: 6